6533b82efe1ef96bd1293f1a
RESEARCH PRODUCT
Contrast-enhanced ultrasound of hepatocellular carcinoma: where do we stand?
Massimo MidiriRoberto LagallaAdele TaibbiTommaso Vincenzo Bartolottasubject
medicine.medical_specialtyLiver perfusionlcsh:Medical technologyHepatocellular carcinomaDiagnostic accuracyReview Article030218 nuclear medicine & medical imagingUltrasound contrast mediaLiver cirrhosi03 medical and health sciences0302 clinical medicinemedicineContrast-enhanced ultrasonographyRadiology Nuclear Medicine and imagingUltrasound contrast mediaUltrasonographybusiness.industryUltrasoundmedicine.diseasePatient managementlcsh:R855-855.5LiverHepatocellular carcinomaLiver cirrhosis030211 gastroenterology & hepatologyRadiologyUltrasonographybusinessSettore MED/36 - Diagnostica Per Immagini E RadioterapiaContrast-enhanced ultrasounddescription
Contrast-enhanced ultrasound (CEUS) represents a significant breakthrough in ultrasonography (US), and it is being increasingly used for the evaluation of focal liver lesions (FLLs). CEUS is unique in that it allows non-invasively assessment of liver perfusion in real time throughout the vascular phase, which has led to dramatic improvements in the diagnostic accuracy of US in the detection and characterization of FLLs, the choice of therapeutic procedures, and the evaluation of response. Currently, CEUS is included as a part of the suggested diagnostic work-up of FLLs, including in cirrhotic patients with hepatocellular carcinoma, resulting in better patient management and cost-effective delivery of therapy.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2019-07-01 | Ultrasonography |